Skip to main content
Premium Trial:

Request an Annual Quote

RADx Awards Minute Molecular Diagnostics $21.3M for Rapid PCR COVID-19 Test

NEW YORK – Minute Molecular Diagnostics has been awarded a $21.3 million contract from the US National Institutes of Health Rapid Acceleration of Diagnostics, or RADx, program to support the development of its Diagnostic Analyzer for Specific Hybridization, or DASH, PCR system and SARS-CoV-2 assay.

The DASH system is a rapid, cartridge-based, point-of-care molecular diagnostics instrument codeveloped by Evanston, Illinois-based Minute Molecular and Northwestern University's Center for Innovation in Global Health Technologies. The DASH SARS-CoV-2 assay tests patient samples directly from nasal swabs, providing PCR results in approximately 15 minutes. 

"We are pleased to receive support from NIH through the RADx initiative to scale our innovative technology during this critical time of need," said David Kelso, president and CEO of Minute Molecular Diagnostics, in a statement. "DASH performs point-of-care PCR testing for COVID-19 in approximately 15 minutes, providing an important, new tool for safely reopening K-12 schools, universities, and workplaces," he said.

RADx has awarded more than $1.2 billion to developers to support SARS-CoV-2 diagnostics scale up.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.